NASDAQ:ACON

Aclarion Stock Insider Trading

Healthcare > Medical - Healthcare Information Services

Buy ACON

*Your capital is at risk

$2.25

+0.230 (+11.39%)

At Close: Jul 31, 2026

Aclarion Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 5.15B and sold 2.49M ACON shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	5.15B shares
● Sell	2.49M shares
94% Buy Activity Moderate Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 29, 2022 Buy	Common Stock P-Purchase	Lorbiecki John Paul Chief Financial Officer	C-Suite Officer	18 304 Value: $8K
Dec 29, 2022 Buy	Common Stock P-Purchase	Lorbiecki John Paul Chief Financial Officer	C-Suite Officer	4 100 Value: $2K
Dec 29, 2022 Buy	Stock option (right to buy) A-Award	Wesemann William Director	Director	63 000 Value: $0
Dec 29, 2022 Buy	Common Stock P-Purchase	Lorbiecki John Paul Chief Financial Officer	C-Suite Officer	4 100 Value: $2K
Dec 29, 2022 Buy	Common Stock P-Purchase	Lorbiecki John Paul Chief Financial Officer	C-Suite Officer	18 304 Value: $8K
Dec 29, 2022 Buy	Common Stock P-Purchase	Ness Brent Chief Executive Officer	CEO / President	8 500 Value: $4K
Dec 29, 2022 Buy	Common Stock P-Purchase	Ness Brent Chief Executive Officer	CEO / President	7 711 Value: $4K
Dec 28, 2022 Buy	Common Stock P-Purchase	Ness Brent Chief Executive Officer	CEO / President	2 289 Value: $961
Dec 28, 2022 Buy	Common Stock P-Purchase	Ness Brent Chief Executive Officer	CEO / President	2 289 Value: $961
Dec 02, 2022 Buy	Common Stock J-Other	Neal David K Director	Director	152 128 Value: $0
Dec 02, 2022 Buy	Common Stock J-Other	Neal David K Director	Director	152 128 Value: $0
Dec 02, 2022 Sell	Common Stock J-Other	Sc Capital 1 Llc Director	Director	1 091 894 Value: $0
Dec 02, 2022 Sell	Common Stock J-Other	Neal David K Director	Director	152 128 Value: $0
Dec 02, 2022 Sell	Common Stock J-Other	Neal David K Director	Director	152 128 Value: $0
Dec 02, 2022 Sell	Common Stock J-Other	Sc Capital 1 Llc Director	Director	1 091 894 Value: $0
Apr 22, 2022 Buy	Warrants for Common Stock (right to buy) P-Purchase	Bond Ryan Chief Strategy Officer	Officer	21 000 Value: $15.3K
Apr 22, 2022 Buy	Warrants for Common Stock (right to buy) P-Purchase	Bond Ryan Chief Strategy Officer	Officer	21 000 Value: $15.3K
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Breidbart Scott	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Sequira Amanda Mae	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Deitsch Stephen	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Deitsch Stephen Director	Director	63 000 Value: $171.4K
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Breidbart Scott	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Sequira Amanda Mae	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Deitsch Stephen	Director	63 000 Value: $0
Apr 22, 2022 Buy	Stock option (right to buy) A-Award	Deitsch Stephen Director	Director	63 000 Value: $171.4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ACLARION, INC.

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclari...

Read Full Profile Here